These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23744143)

  • 21. [Stem cell kinetics of bone marrow in relation to cytostatic treatment].
    Laerum OD
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1207-9 passim. PubMed ID: 4935674
    [No Abstract]   [Full Text] [Related]  

  • 22. [Review on experimental studies of Chinese drugs in antagonizing bone marrow inhibition caused by chemicals].
    Yang T; Deng D
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Aug; 19(8):506-8. PubMed ID: 11783234
    [No Abstract]   [Full Text] [Related]  

  • 23. [Disorders of bone marrow hematopoiesis long time after the action of cytostatic preparations].
    Bogdashin IV; Sycheva EV; Zhdanov VV; Afanas'eva ON; Zapuskalova OP; Novitskiĭ VV; Gol'dberg ED
    Biull Eksp Biol Med; 1992 Mar; 113(3):283-4. PubMed ID: 1421227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization.
    Berger MG; Berger J; Richard C; Jeanpierre S; Nicolini FE; Tournilhac O; Michallet M; Maguer-Satta V
    Leukemia; 2008 Nov; 22(11):2131-4. PubMed ID: 18596744
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects on bone marrow during stimulation of hematopoietic stem cells with recombinant human interleukin-3].
    Falk S; Seipelt G; Ganser A; Hoelzer D; Stutte HJ; Hübner K
    Verh Dtsch Ges Pathol; 1990; 74():111-5. PubMed ID: 1708566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy.
    Brenet F; Kermani P; Spektor R; Rafii S; Scandura JM
    J Exp Med; 2013 Mar; 210(3):623-39. PubMed ID: 23440043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospects for eradication of therapy-induced myelosuppression.
    Ventura G; Spitzer G; Hester J; Deisseroth A
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():41-2. PubMed ID: 1969309
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bone marrow regenerative phenomena after antimitotic therapy].
    Castoldi GL
    Minerva Med; 1966 Mar; 57(25):1102-6. PubMed ID: 5932011
    [No Abstract]   [Full Text] [Related]  

  • 29. Adult stem cell mobilization enhances intramembranous bone regeneration: a pilot study.
    McNulty MA; Virdi AS; Christopherson KW; Sena K; Frank RR; Sumner DR
    Clin Orthop Relat Res; 2012 Sep; 470(9):2503-12. PubMed ID: 22528386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of therapeutic schedules for administering granulocyte colony-stimulating factor to nonhuman primates after high-dose chemotherapy.
    Meisenberg BR; Davis TA; Melaragno AJ; Stead R; Monroy RL
    Blood; 1992 May; 79(9):2267-72. PubMed ID: 1373969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. O6-benzylguanine potentiates the in vivo toxicity and clastogenicity of temozolomide and BCNU in mouse bone marrow.
    Chinnasamy N; Rafferty JA; Hickson I; Ashby J; Tinwell H; Margison GP; Dexter TM; Fairbairn LJ
    Blood; 1997 Mar; 89(5):1566-73. PubMed ID: 9057638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo acute hematotoxicity of N,N'-bis[N-(2-chloroethyl)-N-nitrosocarbamoyl]cystamine (CNCC), a new nitrosourea analog.
    Blazsek I; Mathé G; Maral R; Jasmin C
    Toxicol Appl Pharmacol; 1984 Jun; 74(2):250-7. PubMed ID: 6740675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of indirubin on hemopoietic cell production (author's transl)].
    Wan JH; You YC; Mi JX; Ying HG
    Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):241-4. PubMed ID: 6462023
    [No Abstract]   [Full Text] [Related]  

  • 34. Hematologic complications of cancer chemotherapy.
    Hoagland HC
    Semin Oncol; 1982 Mar; 9(1):95-102. PubMed ID: 7071611
    [No Abstract]   [Full Text] [Related]  

  • 35. The enhancement of haemopoietic stem cell recovery in irradiated mice by prior treatment with cyclophosphamide.
    Blackett NM; Aguado M
    Cell Tissue Kinet; 1979 May; 12(3):291-8. PubMed ID: 476777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of correlation between proliferative and colony-forming assays and the true regenerative potential of transplanted bone marrow.
    Sutton P; Waring P; Müllbacher A
    Transpl Immunol; 1994 Dec; 2(4):348-9. PubMed ID: 7535645
    [No Abstract]   [Full Text] [Related]  

  • 37. [The role of SC-1(+)- and Thy-1(+)-cells in the regulation of cytokine production by cells of the bone marrow regenerating after cytostatic action].
    Dygaĭ AM; Sherstoboev EIu; Gol'dberg ED
    Biull Eksp Biol Med; 1998 Apr; 125(4):374-7. PubMed ID: 9631712
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacological purging of bone marrow with drugs other than cyclophosphamide derivatives.
    Gorin NC
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):437-46. PubMed ID: 2419956
    [No Abstract]   [Full Text] [Related]  

  • 39. Sensitivity of normal and neoplastic cells to chemotherapeutic agents in vitro.
    Dow LW
    Adv Intern Med; 1980; 25():427-52. PubMed ID: 6987848
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of erythropoietin on regeneration of hematopoietic stem cells after 5-fluorouracil administration.
    Reissmann KR; Samorapoompichit S
    J Lab Clin Med; 1969 Apr; 73(4):544-50. PubMed ID: 5775126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.